Cargando…

Atopic dermatitis: a need to define the disease activity

Detalles Bibliográficos
Autores principales:	De Greef, Axel, de Montjoye, Laurence, Bieber, Thomas, Baeck, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654964/ https://www.ncbi.nlm.nih.gov/pubmed/38020127 http://dx.doi.org/10.3389/fmed.2023.1293185

Ejemplares similares

Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and Adults
por: De Greef, Axel, et al.
Publicado: (2023)

Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study
por: De Greef, Axel, et al.
Publicado: (2023)

Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
por: Bieber, Thomas
Publicado: (2021)

Atopic dermatitis: a paradigmatic allergic skin disease.
por: Bieber, T
Publicado: (2001)

Chronic spontaneous urticaria following COVID-19 vaccination
por: de Montjoye, Laurence, et al.
Publicado: (2022)

Barrier function and microbiotic dysbiosis in atopic dermatitis
por: Seite, Sophie, et al.
Publicado: (2015)

Atopic Dermatitis Studies through In Vitro Models
por: De Vuyst, Evelyne, et al.
Publicado: (2017)

Potential biomarkers of atopic dermatitis
por: Yu, Ling, et al.
Publicado: (2022)

Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
por: Bernardo, Diana, et al.
Publicado: (2023)

Itch in Atopic Dermatitis – What Is New?
por: Legat, Franz J.
Publicado: (2021)

Atopic dermatitis phenotypes and the need for personalized medicine
por: Cabanillas, Beatriz, et al.
Publicado: (2017)

Atopic dermatitis and chronic kidney disease: a bidirectional Mendelian randomization study
por: Zhang, Han, et al.
Publicado: (2023)

Clinical trials of antibody drugs in the treatments of atopic dermatitis
por: Zhou, Guihao, et al.
Publicado: (2023)

IgE-Selective Immunoadsorption for Severe Atopic Dermatitis
por: Kasperkiewicz, Michael, et al.
Publicado: (2018)

Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16
por: Thyssen, Jacob P., et al.
Publicado: (2023)

Comparison of Gut Viral Communities in Atopic Dermatitis and Healthy Children
por: Lu, Xiang, et al.
Publicado: (2022)

The relationship between atopic dermatitis and atopic itch in children and the psychosocial functioning of their mothers: A cross-sectional study
por: Kobusiewicz, Aleksandra K., et al.
Publicado: (2023)

Atopic Dermatitis: Clinical Aspects and Unmet Needs
por: Lobefaro, Fabio, et al.
Publicado: (2022)

Atopic dermatitis
por: Werfel, Thomas
Publicado: (2011)

Pandemic chilblains: Are they SARS-CoV-2-related or not?
por: De Greef, Axel, et al.
Publicado: (2022)

Altered Serum Phospholipids in Atopic Dermatitis and Association with Clinical Status
por: Sakai, Takashi, et al.
Publicado: (2021)

The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis
por: Napolitano, Maddalena, et al.
Publicado: (2023)

Gut microbiota and atopic dermatitis: a two-sample Mendelian randomization study
por: Xue, Yan, et al.
Publicado: (2023)

Atopic dermatitis
por: Galli, Elena, et al.
Publicado: (2020)

Atopic dermatitis epidemiology and unmet need in the United Kingdom
por: Cork, Michael J., et al.
Publicado: (2019)

Burden of Disease and Unmet Needs in the Diagnosis and Management of Atopic Dermatitis in Korea
por: Woo, Yu Ri, et al.
Publicado: (2023)

Case Report: The Application of Dupilumab in Atopic Dermatitis Children Complicated With Nephrotic Syndrome
por: Yang, Ya-Qi, et al.
Publicado: (2022)

Developing integrated care pathways for atopic dermatitis—Challenges and unmet needs
por: Zuberbier, Torsten, et al.
Publicado: (2023)

Psoriasis and Atopic Dermatitis
por: Griffiths, Christopher E. M., et al.
Publicado: (2017)

Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents
por: Caffarelli, Carlo, et al.
Publicado: (2023)

Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study
por: Zhou, Bingjing, et al.
Publicado: (2022)

Ocular Adverse Effects in Atopic Dermatitis Patients Treated With Dupilumab: A Bibliometric Analysis
por: Jia, Qian-Nan, et al.
Publicado: (2022)

Reducing scratching behavior in atopic dermatitis patients using the EMDR treatment protocol for urge: A pilot study
por: de Veer, Mathijs R., et al.
Publicado: (2023)

Extracellular matrix and dermal nerve growth factor dysregulation in prurigo nodularis compared to atopic dermatitis
por: Deng, Junwen, et al.
Publicado: (2022)

Autoimmunity (or Not) in Atopic Dermatitis
por: Roesner, Lennart M., et al.
Publicado: (2019)

Burden of Disease, Unmet Needs in the Diagnosis and Management of Atopic Dermatitis: An Indian Expert Consensus
por: Rajagopalan, Murlidhar, et al.
Publicado: (2021)

Autoallergy in atopic dermatitis
por: Hradetzky, Susanne, et al.
Publicado: (2015)

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
por: Le, Michelle, et al.
Publicado: (2021)

Case report: Optical coherence tomography for monitoring biologic therapy in psoriasis and atopic dermatitis
por: Ha-Wissel, Linh, et al.
Publicado: (2022)

Atopic dermatitis
por: Watson, Wade, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3ege9m6ji1r7thhvngh2rfr2kl